Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based “CONSTANCES” cohort
- 6 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in European Journal of Epidemiology
- Vol. 36 (2), 219-222
- https://doi.org/10.1007/s10654-020-00716-2
Abstract
Using serum samples routinely collected in 9144 adults from a French general population-based cohort, we identified 353 participants with a positive anti-SARS-CoV-2 IgG test, among whom 13 were sampled between November 2019 and January 2020 and were confirmed by neutralizing antibodies testing. Investigations in 11 of these participants revealed experience of symptoms possibly related to a SARS-CoV-2 infection or situations at risk of potential SARS-CoV-2 exposure. This suggests early circulation of SARS-CoV-2 in Europe.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-10-COHO-06)
- Santé Publique France (20DMIA014-0)
This publication has 8 references indexed in Scilit:
- Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in ItalyTumori Journal, 2020
- Validation of a commercially available SARS-CoV-2 serological immunoassayClinical Microbiology & Infection, 2020
- Hospital and Population-Based Evidence for COVID-19 Early Circulation in the East of FranceInternational Journal of Environmental Research and Public Health, 2020
- SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoringScience of The Total Environment, 2020
- Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donorsAntiviral Research, 2020
- SARS-CoV-2 was already spreading in France in late December 2019International Journal of Antimicrobial Agents, 2020
- The French CONSTANCES population-based cohort: design, inclusion and follow-upEuropean Journal of Epidemiology, 2015